BridgeBio Pharma, Inc. (BIT:1BBIO)
Italy · Delayed Price · Currency is EUR 36.20
0.00 (0.00%)
At close: Jul 24, 2025, 5:30 PM CET
BridgeBio Pharma Revenue
BridgeBio Pharma had revenue of $116.63M USD in the quarter ending March 31, 2025, a decrease of -44.76%. This brings the company's revenue in the last twelve months to $127.42M, down -41.71% year-over-year. In the year 2024, BridgeBio Pharma had annual revenue of $221.90M with 2,285.27% growth.
Revenue (ttm)
$127.42M
Revenue Growth
-41.71%
P/S Ratio
63.54
Revenue / Employee
$174.54K
Employees
730
Market Cap
7.49B EUR
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UniCredit | 24.79B |
| Intesa Sanpaolo | 25.43B |
| Enel SpA | 78.35B |
| Ferrari | 6.88B |
| Assicurazioni Generali | 55.30B |
| Eni S.p.A. | 90.96B |
| Leonardo S.p.a. | 18.26B |
| Stellantis | 156.88B |